Selected research
Industry Research
Asthma Management Products Industry Research Report 2026
Market perspective
The global Asthma Management Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Asthma Management Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Asthma Management Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Asthma Management Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Asthma Management Products include Boehringer Ingelheim, F. Hoffmann-La Roche, GE Healthcare, Sanofi-Aventis, AstraZeneca, Baxter, GlaxoSmithKline, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Asthma Management Products market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Asthma Management Products Market by Company
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Sanofi-Aventis
AstraZeneca
Baxter
GlaxoSmithKline
Merck
Novartis
Teva Pharmaceutical Industries
Asthma Management Products Segment by Type
Corticosteroids
Bronchodilators
Others
Asthma Management Products Segment by Application
Online Pharmacy
Hospital Pharmacy
Drug Stores
Retail Pharmacy
Asthma Management Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Management Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Asthma Management Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Management Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Asthma Management Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Asthma Management Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Asthma Management Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Corticosteroids
- Bronchodilators
- Others
Applications
- Online Pharmacy
- Hospital Pharmacy
- Drug Stores
- Retail Pharmacy
Companies covered
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- GE Healthcare
- Sanofi-Aventis
- AstraZeneca
- Baxter
- GlaxoSmithKline
- Merck
- Novartis
- Teva Pharmaceutical Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Asthma Management Products Market Size (2021-2032)
- 2.2.2 Global Asthma Management Products Sales (2021-2032)
- 2.2.3 Global Asthma Management Products Market Average Price (2021-2032)
- 2.3 Asthma Management Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Corticosteroids
- 2.3.3 Bronchodilators
- 2.3.4 Others
- 2.4 Asthma Management Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Pharmacy
- 2.4.3 Hospital Pharmacy
- 2.4.4 Drug Stores
- 2.4.5 Retail Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Asthma Management Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Asthma Management Products Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Asthma Management Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Asthma Management Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Asthma Management Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Asthma Management Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Asthma Management Products, Product Type & Application
- 3.8 Global Manufacturers of Asthma Management Products, Established Date
- 3.9 Global Asthma Management Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Asthma Management Products Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 F. Hoffmann-La Roche
- 4.2.1 F. Hoffmann-La Roche Company Information
- 4.2.2 F. Hoffmann-La Roche Business Overview
- 4.2.3 F. Hoffmann-La Roche Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 F. Hoffmann-La Roche Asthma Management Products Product Portfolio
- 4.2.5 F. Hoffmann-La Roche Recent Developments
- 4.3 GE Healthcare
- 4.3.1 GE Healthcare Company Information
- 4.3.2 GE Healthcare Business Overview
- 4.3.3 GE Healthcare Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GE Healthcare Asthma Management Products Product Portfolio
- 4.3.5 GE Healthcare Recent Developments
- 4.4 Sanofi-Aventis
- 4.4.1 Sanofi-Aventis Company Information
- 4.4.2 Sanofi-Aventis Business Overview
- 4.4.3 Sanofi-Aventis Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi-Aventis Asthma Management Products Product Portfolio
- 4.4.5 Sanofi-Aventis Recent Developments
- 4.5 AstraZeneca
- 4.5.1 AstraZeneca Company Information
- 4.5.2 AstraZeneca Business Overview
- 4.5.3 AstraZeneca Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AstraZeneca Asthma Management Products Product Portfolio
- 4.5.5 AstraZeneca Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Asthma Management Products Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 GlaxoSmithKline
- 4.7.1 GlaxoSmithKline Company Information
- 4.7.2 GlaxoSmithKline Business Overview
- 4.7.3 GlaxoSmithKline Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxoSmithKline Asthma Management Products Product Portfolio
- 4.7.5 GlaxoSmithKline Recent Developments
- 4.8 Merck
- 4.8.1 Merck Company Information
- 4.8.2 Merck Business Overview
- 4.8.3 Merck Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck Asthma Management Products Product Portfolio
- 4.8.5 Merck Recent Developments
- 4.9 Novartis
- 4.9.1 Novartis Company Information
- 4.9.2 Novartis Business Overview
- 4.9.3 Novartis Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Novartis Asthma Management Products Product Portfolio
- 4.9.5 Novartis Recent Developments
- 4.10 Teva Pharmaceutical Industries
- 4.10.1 Teva Pharmaceutical Industries Company Information
- 4.10.2 Teva Pharmaceutical Industries Business Overview
- 4.10.3 Teva Pharmaceutical Industries Asthma Management Products Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Pharmaceutical Industries Asthma Management Products Product Portfolio
- 4.10.5 Teva Pharmaceutical Industries Recent Developments
5 Global Asthma Management Products Market Scenario by Region
- 5.1 Global Asthma Management Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Asthma Management Products Sales by Region: 2021-2032
- 5.2.1 Global Asthma Management Products Sales by Region: 2021-2026
- 5.2.2 Global Asthma Management Products Sales by Region: 2027-2032
- 5.3 Global Asthma Management Products Revenue by Region: 2021-2032
- 5.3.1 Global Asthma Management Products Revenue by Region: 2021-2026
- 5.3.2 Global Asthma Management Products Revenue by Region: 2027-2032
- 5.4 North America Asthma Management Products Market Facts & Figures by Country
- 5.4.1 North America Asthma Management Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Asthma Management Products Sales by Country (2021-2032)
- 5.4.3 North America Asthma Management Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Asthma Management Products Market Facts & Figures by Country
- 5.5.1 Europe Asthma Management Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Asthma Management Products Sales by Country (2021-2032)
- 5.5.3 Europe Asthma Management Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Asthma Management Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Asthma Management Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Asthma Management Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Asthma Management Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Asthma Management Products Market Facts & Figures by Country
- 5.7.1 South America Asthma Management Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Asthma Management Products Sales by Country (2021-2032)
- 5.7.3 South America Asthma Management Products Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Asthma Management Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Asthma Management Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Asthma Management Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Asthma Management Products Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Asthma Management Products Sales by Type (2021-2032)
- 6.1.1 Global Asthma Management Products Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Asthma Management Products Sales Market Share by Type (2021-2032)
- 6.2 Global Asthma Management Products Revenue by Type (2021-2032)
- 6.2.1 Global Asthma Management Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Asthma Management Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Asthma Management Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Asthma Management Products Sales by Application (2021-2032)
- 7.1.1 Global Asthma Management Products Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Asthma Management Products Sales Market Share by Application (2021-2032)
- 7.2 Global Asthma Management Products Revenue by Application (2021-2032)
- 7.2.1 Global Asthma Management Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Asthma Management Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Asthma Management Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Asthma Management Products Value Chain Analysis
- 8.1.1 Asthma Management Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Asthma Management Products Production Mode & Process
- 8.2 Asthma Management Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Asthma Management Products Distributors
- 8.2.3 Asthma Management Products Customers
9 Global Asthma Management Products Analyzing Market Dynamics
- 9.1 Asthma Management Products Industry Trends
- 9.2 Asthma Management Products Industry Drivers
- 9.3 Asthma Management Products Industry Opportunities and Challenges
- 9.4 Asthma Management Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst